AGP Executive Report
Last update: 9 hours agoDigital Health & Sovereign Data: Dassault Systèmes is partnering with PariSanté Campus to help European healthcare startups scale with virtual twins, sovereign cloud infrastructure and AI mentoring that fits EU data-security rules. Cancer Care Update: New subgroup results from the EPCORE FL-1 trial report that epcoritamab plus lenalidomide and rituximab delivers stronger responses and progression-free survival than lenalidomide/rituximab alone in relapsed/refractory follicular lymphoma. Mental Health Biology: A study links major depressive disorder to altered gene activity in white blood cells, pointing to immune-system involvement beyond the brain. Public Health & Heat: WHO issues fresh guidance for heat-health action plans as El Niño conditions intensify. Care Access & Workforce: A conference discussion highlights why primary care reforms often stall long-term, with tensions between local integration efforts and broader systemic change. Blood Supply Push: A donor campaign urges more people to give blood and plasma, citing weekly hospital needs and the role of plasma-derived medicines. EU Migration Law: The EU’s new asylum pact starts 12 June, replacing Dublin rules and reshaping how responsibility is handled for UK claims and arrivals.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
![[Latest] Global Gastrointestinal Endoscopy Devices Market Size/Share Worth USD 19.6 Billion by 2035 at a 5.4% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, SWOT Analysis)](https://ml.globenewswire.com/Resource/Download/af9c6fb4-2b61-4367-852e-7237ba1d9bc4/north-america-gastrointestinal-endoscopy-devices-market-size-2025-to-2035-usd-billion-.png)
